GE HealthCare Technologies AVS — Total revenues decreased by 12.1% to $1.34B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.2%, from $1.24B to $1.34B. Over 2 years (FY 2022 to FY 2025), AVS — Total revenues shows relatively stable performance with a 3.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growing market demand or successful pricing strategies within the segment, while a decrease may signal market saturation or competitive pressure.
Represents the total gross inflow of economic benefits arising from the ordinary operating activities of the specific bu...
Standard revenue reporting across medical technology peers, often categorized by product line or geographic region.
gehc_segment_avs_total_revenues| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.25B | $1.25B | $1.25B | $1.25B | $1.21B | $1.23B | $1.25B | $1.22B | $1.44B | $1.24B | $1.29B | $1.30B | $1.53B | $1.34B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -3.1% | +1.1% | +1.8% | -2.6% | +18.3% | -13.9% | +4.0% | +0.9% | +17.2% | -12.1% |
| YoY Change | — | — | — | — | -3.1% | — | — | +0.2% | — | +1.0% | +3.2% | +7.0% | +6.0% | +8.2% |